Advanced Cell Technology's Dr. Robert Lanza on Explorations in Science Print E-mail
By Staff and Wire Reports   
Thursday, 23 December 2010 06:15
best penny stock picksDr. Robert Lanza, the Chief Scientific Officer of Advanced Cell Technology (OTCBB:ACTC) has been featured and interviewed as "one of the leading scientists making breakthroughs in his field" on Explorations in Science with best-selling author and television personality, Dr. Michio Kaku.

Subscribers Only: Technical Analysis Update for ACTC

ACTC: Rated Strong Buy on 12/23/10

Dr. Michiu Kaku's Radio Programs

Interim CEO, Gary Rabin updates ACTC shareholders

The hour long radio program on science and technology is broadcast each week on WBAI New York City (99.5 FM), and re-aired on stations across the country. The segment focused attention to future of biotech and included a discussion about Lanza’s background including his experiments in the field of animal cloning as well as a brief discourse about his research with myoblast stem cell therapies.

Exploration - December 21, 2010 at 2:00pm

Click to listen (or download)


For only the second time in history, the Food and Drug Administration approved the human trial of a therapy developed from embryonic stem cells when Lanza and the team at Advanced Cell Technology secured approval for human trials of their retinal pigment epithelial cells to treat Stargardt’s Macular Dystrophy.

Robert Lanza, M. D. is considered one of the leading scientists in the world. He serves as Advanced Cell Technology’s Chief Scientific Officer, and Adjunct Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine. He has hundreds of publications and inventions, and over two dozen scientific books: among them, “Principles of Tissue Engineering,” which is recognized as the definitive reference in the field. Others include One World: The Health & Survival of the Human Species in the 21st Century (Foreword by former President and Nobel laureate Jimmy Carter), and the “Handbook of Stem Cells” and “Essentials of Stem Cell Biology,” which are considered the definitive references in stem cell research.

He is a former Fulbright Scholar, and studied as a student in the laboratory of Richard Hynes (MIT), Jonas Salk (The Salk Institute), and Nobel laureates Gerald Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also worked closely (and coauthored a series of papers) with the late Harvard psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard. Dr. Lanza received his B.A. and M.D. Degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar.

Dr. Michio Kaku is a theoretical physicist, best-selling author, and popularizer of science. He’s the co-founder of string field theory (a branch of string theory), and continues Einstein’s search to unite the four fundamental forces of nature into one unified theory. He is a NY Times Bestseller List and has appeared on television (Discovery, BBC, ABC, Science Channel, and CNN to name a few), written for popular science publications like Discover, Wired, and New Scientist, been featured in documentaries like Me & Isaac Newton, and hosted many of his own including BBC’s recent series on Time.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter